US Patent Issued to City University of Hong Kong on March 24 for "Sample-in-result-out closed microfluidic device for nucleic acid molecular point-of-care testing detection" (Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,985, issued on March 24, was assigned to City University of Hong Kong (Hong Kong).

"Sample-in-result-out closed microfluidic device for nucleic acid molecular point-of-care testing detection" was invented by Mengsu Yang (Hong Kong), Bereket Ayele (Hong Kong) and Renardi Gunawan (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "A molecular point-of-care testing (POCT) diagnostic device for molecular detection of various diseases with "sample-in-result-out" principle is provided. The device has a sample tube in which a test sample is mixed with a sample buffer, a microfluidic-based reaction tube with a simple flow-based system for amplifying ...